Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the skin cancer diagnostics market?

In recent times, there has been a substantial increase in the size of the skin cancer diagnostics market. The market, which was valued at $3.13 billion in 2024, is predicted to reach $3.39 billion in 2025, recording a compound annual growth rate (CAGR) of 8.4%. Increased skin cancer incidence, the rising population of aging individuals, heightened awareness and educational programs, as well as government efforts towards early detection have all contributed to this growth during the historical period.

What will be the skin cancer diagnostics market size in the future?

Predictions reveal that the skin cancer diagnostics market is likely to experience robust expansion in the coming years. A rise to $4.69 billion by 2029 is anticipated, with a compound annual growth rate (CAGR) of 8.4%. This projected uptick during the forecast period can be credited to increased awareness of sun exposure risks, implementation of personalized medicine strategies, advancements in telemedicine and remote monitoring, and the worldwide growth of healthcare infrastructure. Factors expected to shape the market trend during this time include the incorporation of digital health systems, development of new and innovative skin cancer medicines, multidisciplinary methodologies, innovations in dermatopathology, and initiatives focused on patient learning and consciousness.

Get your skin cancer diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/skin-cancer-diagnostics-global-market-report

What main drivers are fueling expansion in the skin cancer diagnostics market?

The escalation in melanoma occurrences is projected to drive the expansion of the skin cancer diagnostics market. Melanoma, a variation of skin cancer, originates in the cells that produce melanin – the pigment accountable for skin color, hair, and eyes. Diagnostics for skin cancer are critical for spotting and detailing skin lesions, facilitating early detection, precise diagnosis, and effective treatment strategies for skin cancer. As per the 2023 report by the American Cancer Society Inc., a voluntarily comprehensive health organization in the U.S. purposed to eradicate cancer, the count of males with melanoma in the U.S. rose from 57,180 in 2022 to 58,120 in 2023. Moreover, in March 2023, as per the American Society of Clinical Oncology, a U.S based professional association embracing all oncology doctors, melanoma represents nearly 1% of all skin cancers diagnosed in the U.S., and yet, is accountable for most skin cancer-related deaths. Predicted melanoma fatalities for 2023 in the U.S. stand at 7,990 (5,420 males and 2,570 females). Hence, a surge in melanoma cases is fueling the growth of the skin cancer diagnostics market.

What key areas define the segmentation of the global skin cancer diagnostics market?

The skin cancer diagnostics market covered in this report is segmented –

1) By Cancer Type: Basal Cell Carcinoma, Squamous Cell Carcinoma, Malignant Melanoma, Other Cancer Types

2) By Type: Diagnosis, Therapeutics

3) By Application: Hospital, Clinic, Laboratory, Other Applications

Subsegments:

1) By Basal Cell Carcinoma: Diagnostic imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests

2) By Squamous Cell Carcinoma: Diagnostic imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests

3) By Malignant Melanoma: Diagnostic Imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests

4) By Other Cancer Types: Non-Melanoma Skin Cancers, Dermatofibrosarcoma Protuberans, Merkel Cell Carcinoma

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11914&type=smp

Who are the dominant players expanding their reach in the skin cancer diagnostics market?

Major companies operating in the skin cancer diagnostics market include Pfizer Inc., F. Hoffmann-La Roche Limited, Merck & Co., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sanofi, Eli Lilly and Company, Canon Medical Systems Corporation, Amgen Inc., GE Healthcare, Daiichi Sankyo Company Limited., National Cancer Institute, Agilent Technologies Inc., bioMerieux SA, Teva Pharmaceutical Industries, Bruker Corp, Almirall, Genentech, Castle Biosciences, Sun Pharmaceutical Industries Limited., American Academy of Dermatology, Biolitec Ag, Alma Lasers, DermTech Inc., SkylineDx BV, DermLite LLC, AMLo Biosciences Limited

How are evolving market trends shaping skin cancer diagnostics Strategies?

Top-tier firms in the skin cancer diagnostics market are prioritizing the development of innovative products, like the PRAME protein, to boost detection and treatment options for melanoma and other types of skin cancers. PRAME, an acronym for Preferentially Expressed Antigen in Melanoma, is an antigen linked to cancer/testis that shows promise as a biomarker in diagnosing melanoma. For instance, in October of 2022, Roche, a global healthcare company from Switzerland, unveiled the PRAME (EPR20330) Antibody. The PRAME (EPR20330) Antibody is an antigen associated with melanoma that specializes in identifying PRAME protein expression in tissue samples drawn from individuals who are suspected to have melanoma. This antibody aids in differentiating between benign and malignant growths. Identifying PRAME expression indicates malignancy, a crucial factor in precise diagnosis and the outlining of a treatment plan.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11914

Which regions are emerging as leaders in the skin cancer diagnostics market?

North America was the largest region in the skin cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Retail And Wholesale Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/retail-and-wholesale-global-market-report

Personal Care Shower And Bath Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/personal-care-shower-and-bath-global-market-report

Natural Hair Care Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/natural-hair-care-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: